Women with severe coronary heart disease causing narrowing or blockages in the arteries may derive greater long-term benefits from coronary artery ...
21d
Medical 21, Inc. Announces Regulatory Approval to Initiate First-in-Human Clinical Study in Spain
Medical 21, Inc., a private medical technology company developing a novel regenerative small-diameter coronary bypass graft, today announced that it has received regulatory approval in Spain under the ...
The AHA's scientific statement on coronary artery revascularization in older adults proposes an individualized, patient-centered approach that accounts for age-related physiologic changes and ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
SAN JOSE, Calif.--(BUSINESS WIRE)--AngioSafe ® today announced its emergence from stealth with 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its flagship product, the Santreva™ ...
AngioSafe ® today announced its emergence from stealth with 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for its flagship product, the Santreva™-ATK Endovascular ...
WASHINGTON -- Since reimbursement has improved for coronary revascularization at ambulatory surgery centers (ASCs), outpatients going this route have been few but fairly well selected. Medicare claims ...
Wellington Regional Medical Center has successfully completed its 100th transcarotid artery revascularization (TCAR) procedure. TCAR is a minimally invasive procedure for carotid artery disease that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback